Sales of Hershey's Ice Breakers rose 8% in the first quarter, thanks to the trend.
Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.
Despite a top- and bottom-line beat for the first quarter, Hershey is trading defensively in Thursday’s premarket open as ...
Q1 2026 earnings call highlights: steady demand, rational pricing, Q2 timing dip, and margin expansion outlook.
The Hershey Co. says its gum and mint sales are increasing, with demand potentially linked to reports of "Ozempic breath" among users of GLP-1 weight loss drugs.
While CEO Kirk Tanner didn't specify the connection, GLP-1 drug users have documented an unofficial side effect commonly ...
Hershey on Thursday beat Wall Street expectations for quarterly revenue and profit as higher prices and demand for its ...
By Juveria Tabassum and Alexander Marrow April 30 (Reuters) - Hershey beat first-quarter earnings estimates, helped by strong ...
Hershey’s Q1 2026 results show revenue up 10.6%, organic sales growth of 7.9% and a sharp rebound in profits, signalling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results